IDEXX Laboratories, Inc. (IDXX) is expected to report earnings on Monday, November 2, 2026, after the close. Estimated release time 06:31 ET. Consensus EPS estimate is $3.71.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q2 | $3.94 | $4.23 | +7.4% | $1.22B |
| 2026-05-05 | FY2026 Q1 | $3.41 | $3.48 | +2.1% | $1.14B |
| 2026-02-20 | FY2025 Q4 | $2.93 | $3.10 | +5.8% | $1.09B |
| 2025-11-03 | FY2025 Q3 | $3.14 | $3.43 | +9.2% | $1.11B |
| 2025-08-04 | FY2025 Q2 | $3.28 | $3.66 | +11.6% | $1.11B |
| 2025-05-01 | FY2025 Q1 | $2.85 | $2.98 | +4.6% | $998.43M |
| 2025-02-21 | FY2024 Q4 | $2.39 | $2.63 | +10.0% | $954.29M |
| 2024-10-31 | FY2024 Q3 | $2.68 | $2.83 | +5.6% | $975.54M |
IDXX has beaten consensus EPS in 8 of its last 8 reported quarters.
See IDXX on the live calendar →